|
A |
B |
C |
D |
E |
F |
G |
H |
I |
J |
K |
L |
M |
N |
O |
P |
Q |
R |
S |
T |
U |
V |
W |
X |
Y |
Z
Recent news on
Moxifloxacin Hcl
Efficacy of Once-Daily Moxifloxacin in Treating Complicated Intra ... Oct 13, 2006 SAN FRANCISCO, CA -- October 13, 2006 -- The efficacy of monotherapy with the once-daily, broad-spectrum antibiotic Avelox® (moxifloxacin HCl) in the ... -DG News
Quest for New Antibiotics to Fight Drug Resistant Infections Gets ... Sep 12, 2006 ...of death in America's senior citizens 65 and older, but there appears to be new hope in this battle from a newer antibiotic, moxifloxacin HCl, marketed as ... -SeniorJournal.com
Avelox (Moxifloxacin) Excels in Comparison with Highly Potent ... Sep 5, 2006 5, 2006--Avelox® (moxifloxacin HCl) 400mg sequential intravenous to oral monotherapy given once a day is as effective as the potent combination of high-dose ... -PharmaLive.com
Avelox(R) (Moxifloxacin) excels in comparison with highly potent ... Sep 6, 2006 LEVERKUSEN, Germany | Sep 05, 2006 | Avelox® (moxifloxacin HCl) 400mg sequential intravenous to oral monotherapy given once a day is as effective as the ... -PipelineReview.com
Study shows Avelox monotherapy to be a highly effective, safe and ... Sep 6, 2006 5 Sep 2006 , Leverkusen : Avelox® (moxifloxacin HCl) 400mg sequential intravenous to oral monotherapy given once a day is as effective as the potent ... -Prdomain Business Register
Avelox As Effective As Multi-dose Combination Therapy For Intra ... Jul 28, 2006 Schering-Plough Corporation (NYSE: SGP) today reported that monotherapy with the once-daily, broad-spectrum antibiotic AVELOX (moxifloxacin HCl) was as ... -Medical News Today
Schering’s AVELOX® Shown Effective in Study and Merck Announces ... Jul 26, 2006 Schering-Plough Corporation (NYSE: SGP) recently reported that monotherapy with the once-daily, broad-spectrum antibiotic AVELOX® (moxifloxacin HCl) was as ... -Financial News USA
Avelox As Effective As Multi-Dose Combination Therapy for Intra ... Jul 26, 2006 Schering-Plough Corporation reported that monotherapy with the once-daily, broad-spectrum antibiotic AVELOX (moxifloxacin HCl) was as effective and well ... -eMaxHealth.com
Schering-Plough Reports Financial Results for First Quarter of ... Apr 20, 2006 ...(Announced March 20) * Reported results of a new clinical study showing that AVELOX (moxifloxacin HCl) monotherapy at 400 mg once daily was as effective as the ... - PR Newswire
Moxifloxacin Monotherapy as Effective as High-Dose Levofloxacin ... Apr 7, 2006 KENILWORTH, NJ -- April 7, 2006 -- Avelox® (moxifloxacin HCl) monotherapy at 400 mg once daily is as effective as the high-dose combination of levofloxacin ... - DG News
AVELOX(R) Monotherapy as Effective as High-Dose Levofloxacin and ... Apr 7, 2006 KENILWORTH, NJ, April 7 /PRNewswire-FirstCall/ -- AVELOX(R) (moxifloxacin HCl) monotherapy at 400 mg once daily is as effective as the high-dose combination of ... - PR Newswire
AVELOX(R) Monotherapy as Effective as High-Dose Levofloxacin and ... Apr 7, 2006 ...of Clinical Microbiology and Infectious Diseases (ECCMID) KENILWORTH, NJ, April 7 /PRNewswire-FirstCall/ -- AVELOX(R) (moxifloxacin HCl) monotherapy at 400 mg ... - PR Newswire
Vaccinated Senior Citizens Less Likely to Die from Pneumonia Mar 16, 2006 ...of death in America's senior citizens 65 and older, but there appears to be new hope in this battle from a newer antibiotic, moxifloxacin HCl, marketed as ... - SeniorJournal.com
Alcon and Allergan Reach Agreement on Brimonidine 0.15% Patent ... Mar 9, 2006 Alcon believes this suit was intended to target Vigamox(R) (0.5% moxifloxacin HCl ophthalmic solution), Alcon's leading ophthalmic ocular antibiotic in the US. ... - Genetic Engineering News
Head-To-Head Study Shows More Elderly Patients With Community ... Jan 24, 2006 24 /PRNewswire-FirstCall/ -- Significantly more elderly patients treated with AVELOX(R) (moxifloxacin HCl) for community-acquired pneumonia (CAP) recovered at ... - PR Newswire
Bayer Drug Better Than Leading Pneumonia Treatment Jan 28, 2006 Significantly more elderly patients treated with the Bayer drug Avelox (moxifloxacin HCl) for community-acquired pneumonia (CAP) recovered at days three to ... - International News Service
Head-To-Head Study Shows More Elderly Patients With Community ... Jan 24, 2006 KENILWORTH, NJ, January 24, 2006 /PRNewswire-FirstCall/ -- Significantly more elderly patients treated with AVELOX(R) (moxifloxacin HCl) for community-acquired ... - PharmaLive.com
Newer Antibiotic more Effective at Treating Pneumonia in Senior ... Jan 24, 2006 ...of death in America's senior citizens 65 and older, but there appears to be new hope in this battle from a newer antibiotic, moxifloxacin HCl, marketed as ... - SeniorJournal.com
Newer Antibiotic More Effective At Treating Elders' Pneumonia Jan 24, 2006 Treated with the newer medication, moxifloxacin HCl, 97.9 percent of hospitalized patients recovered within three to five days of therapy onset, compared to 90 ... - DG News
(PRN) - Emerging Market for Omega-3 Fatty Acids Gains Ground ... ... Jan 24, 2006 ...(PRN) - Head-To-Head Study Shows More Elderly Patients With Community-Acquired Pneumonia Recovered at Days 3 to 5 With AVELOX(R) (Moxifloxacin HCl) Compared to ... - Bolsamania.com
This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional
|